home / stock / nvus / nvus short
Short Information | Novus Therapeutics Inc. (NASDAQ:NVUS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 77,786 |
Total Actual Volume | 638,670 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 3,889 |
Average Short Percentage | 15.38% |
Is there a NVUS Short Squeeze or Breakout about to happen?
See the NVUS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-04-2021 | $15.6 | $14.6 | $15.7712 | $14.6 | 86,021 | 3,816 | 4.44% |
12-31-2020 | $15.11 | $15.4 | $15.59 | $13.655 | 181,495 | 13,779 | 7.59% |
12-30-2020 | $15.0781 | $15 | $15.5662 | $14.935 | 8,578 | 1,844 | 21.5% |
12-29-2020 | $14.7 | $15.14 | $15.3999 | $14.68 | 12,683 | 4,140 | 32.64% |
12-28-2020 | $14 | $14.62 | $14.7 | $13.61 | 27,721 | 6,751 | 24.35% |
12-24-2020 | $15.25 | $13.81 | $15.25 | $13.78 | 24,068 | 2,787 | 11.58% |
12-23-2020 | $16.65 | $14.76 | $16.65 | $14.2502 | 81,427 | 11,588 | 14.23% |
12-22-2020 | $17.18 | $16.5 | $17.95 | $16.1 | 23,131 | 7,483 | 32.35% |
12-21-2020 | $16.35 | $17 | $17.1604 | $16.35 | 12,593 | 2,886 | 22.92% |
12-18-2020 | $18.53 | $16.25 | $18.53 | $16.1 | 31,601 | 4,346 | 13.75% |
12-17-2020 | $18.4 | $18.32 | $19 | $18.06 | 4,968 | 652 | 13.12% |
12-16-2020 | $19.5802 | $18.35 | $19.5802 | $17.97 | 4,764 | 668 | 14.02% |
12-15-2020 | $17.42 | $18.13 | $18.8455 | $17.42 | 11,004 | 709 | 6.44% |
12-14-2020 | $19.97 | $17.84 | $19.97 | $16.47 | 27,058 | 2,935 | 10.85% |
12-11-2020 | $20.25 | $19.97 | $20.6824 | $19.66 | 10,790 | 1,222 | 11.33% |
12-10-2020 | $23.99 | $20 | $23.99 | $19.7968 | 34,914 | 4,186 | 11.99% |
12-09-2020 | $20.37 | $19.79 | $20.91 | $19.79 | 6,094 | 983 | 16.13% |
12-08-2020 | $21.37 | $19.74 | $21.37 | $19.1801 | 30,061 | 5,119 | 17.03% |
12-07-2020 | $22.79 | $21.3 | $22.79 | $21.07 | 13,358 | 1,028 | 7.7% |
12-04-2020 | $22.49 | $22.14 | $22.96 | $22.07 | 6,341 | 864 | 13.63% |
News, Short Squeeze, Breakout and More Instantly...
Novus Therapeutics Inc. Company Name:
NVUS Stock Symbol:
NASDAQ Market:
Novus Therapeutics Inc. Website:
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate AT-1501, a potential best in class anti-CD40L monoclonal antibody ...
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those l...
Former Chief Development and Chief Operating Officer of MyoKardia, Inc. brings extensive clinical development expertise as Novus prepares to conduct up to four Phase 2 clinical trials Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharma...